De novo cancer-related death in Australian liver and cardiothoracic transplant recipients

American Journal of Transplantation

Volumn 13, Issue 5, 2013, Pages 1296-1304

  Na, R ^a   Grulich, A E ^b   Meagher, N S ^a   McCaughan, G W ^c   Keogh, A M ^d   Vajdic, C M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

Cancer; heart transplantation; liver transplantation; lung transplantation; mortality; pediatric transplantation

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CANCER MORTALITY; CANCER OF UNKNOWN PRIMARY SITE; CAUSE OF DEATH; COHORT ANALYSIS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SKIN CANCER;

ADULT; AUSTRALIA; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84876887552     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12192     Document Type: Article

References (31)

1. Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823-2831.
2. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM,. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007; 370: 59-67.
3. Collett D, Mumford L, Banner NR, Neuberger J, Watson C,. Comparison of the incidence of malignancy in recipients of different types of organ: A UK registry audit. Am J Transplant 2010; 10: 1889-1896.
4. Herrero JI, Lorenzo M, Quiroga J, et al. De novo neoplasia after liver transplantation: An analysis of risk factors and influence on survival. Liver Transpl 2005; 11: 89-97.
5. Lindelof B, Jarnvik J, Ternesten-Bratel A, Granath F, Hedblad MA,. Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: A study of the Swedish cohort. Acta Derm Venereol 2006; 86: 219-222.
6. Kiberd BA, Rose C, Gill JS,. Cancer mortality in kidney transplantation. Am J Transplant 2009; 9: 1868-1875.
7. Foster BJ, Dahhou M, Zhang X, Platt RW, Hanley JA,. Change in mortality risk over time in young kidney transplant recipients. Am J Transplant 2011; 11: 2432-2442.
8. Cheung CY, Lam MF, Chu KH, et al. Malignancies after kidney transplantation: Hong Kong renal registry. Am J Transplant 2012; 12: 3039-3046.
9. Jaro MA,. Probabilistic linkage of large public health data files. Stat Med 1995; 14: 491-498.
10. Benden C, Aurora P, Edwards LB, et al. The registry of the international society for heart and lung transplantation: Fourteenth pediatric lung and heart-lung transplantation report 2011. J Heart Lung Transplant 2011; 30: 1123-1132.
11. Swift MB,. Comparison of confidence intervals for a Poisson mean-Further considerations. Commun Stat Theory Methods 2009; 38: 748-759.
12. Rothman KJ, Greenland S, Lash TL,. Modern epidemiology. 3rd Ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2008; p. 254.
13. Rostgaard K,. Methods for stratification of person-time and events-A prerequisite for poisson regression and SIR estimation. Epidemiol Perspect Innov 2008; 5: 1-16.
14. Na R, Grulich AE, Meagher NS, McCaughan G, Keogh AM, Vajdic CM,. Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. Am J Transplant 2013; 13: 174-183.
15. Watt KDS, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR,. Evolution of causes and risk factors for mortality post-liver transplant: Results of the NIDDK long-term follow-up study. Am J Transplant 2010; 10: 1420-1427.
16. Metcalfe MJ, Kutsogiannis DJ, Jackson K, et al. Risk factors and outcomes for the development of malignancy in lung and heart-lung transplant recipients. Can Respir J 2010; 17: e7-13.
17. Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW,. Lymphoma after solid organ transplantation: Risk, response to therapy, and survival at a transplantation center. J Clin Oncol 2009; 27: 3354-3362.
18. Campistol JM, Cuervas-Mons V, Manito N, et al. New concepts and best practices for management of pre- and post-transplantation cancer. Transplant Rev (Orlando) 2012; 26: 261-279.
19. Reshef R, Vardhanabhuti S, Luskin MR, et al. Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder. Am J Transplant 2011; 11: 336-347.
20. Veness MJ, Quinn DI, Ong CS, et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: The Australian experience. Cancer 1999; 85: 1758-1764.
21. Euvrard S, Kanitakis J, Pouteil-Noble C, et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33: 222-229.
22. Ong CS, Keogh AM, Kossard S, Macdonald PS, Spratt PM,. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40: 27-34.
23. Taj MM, Hadzic N, Height SE, et al. Long-term outcome for immune suppression and immune related lymphoproliferative disorder: Prospective data from the United Kingdom children's leukaemia and cancer group registry 1994-2004. Leuk Lymphoma 2012; 53: 842-848.
24. Schubert S, Abdul-Khaliq H, Lehmkuhl HB, et al. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients. Pediatr Transplant 2009; 13: 54-62.
25. Kerkar N, Morotti RA, Madan RP, et al. The changing face of post-transplant lymphoproliferative disease in the era of molecular EBV monitoring. Pediatr Transplant 2010; 14: 504-511.
26. Tsai DE, Douglas L, Andreadis C, et al. EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: Results of a two-arm prospective trial. Am J Transplant 2008; 8: 1016-1024.
27. Webster AC, Wong G, Craig JC, Chapman JR,. Managing cancer risk and decision making after kidney transplantation. Am J Transplant 2008; 8: 2185-2191.
28. Finkenstedt A, Graziadei IW, Oberaigner W, et al. Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients. Am J Transplant 2009; 9: 2355-2361.
29. Sarfati D, Blakely T, Pearce N,. Measuring cancer survival in populations: Relative survival vs cancer-specific survival. Int J Epidemiol 2010; 39: 598-610.
30. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: Twenty-eighth adult heart transplant report 2011. J Heart Lung Transplant 2011; 30: 1078-1094.
31. Christie JD, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: Twenty-eighth adult lung and heart-lung transplant report 2011. J Heart Lung Transplant 2011; 30: 1104-1122.